ABOUT ABBV-744 IN CLINICAL TRIALS FOR NON-SMALL CELL LUNG CANCER (NSCLC)

Participant consumed grapefruit or grapefruit goods within three days before the initial dose of study drug.- "Our study discovered the very important job of your KLF16/MYC regulatory axis in modulating tumor advancement and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, such as OTX015 or ABBV-744, with DDP or g